Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Sep-Oct;59(5):411-2.
doi: 10.4103/0301-4738.83635.

Prostaglandin analogues in angle closure glaucoma

Pulkit Gupta, B S Mahesh, H L Gupta
Comment

Prostaglandin analogues in angle closure glaucoma

Pulkit Gupta et al. Indian J Ophthalmol. 2011 Sep-Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Vyas P, Naik U, Gangaiah JB. Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: A preliminary study. Indian J Ophthalmol. 2011;59:13–6. - PMC - PubMed
    1. Cheng JW, Cai JP, Li Y, Wei RL. A meta-analysis of topical prostaglandin analogs in the treatment of chronic angle-closure glaucoma. J Glaucoma. 2009;18:652–7. - PubMed
    1. How AC, Kumar RS, Chen YM, Su DH, Gao H, Oen FT, et al. A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma. Br J Ophthalmol. 2009;93:782–6. - PubMed
    1. Katz G, Springs CL, Craven ER, Montecchi-Palmer M. Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost. Clin Ophthalmol. 2010;4:1253–61. - PMC - PubMed
    1. Miyashiro MJ, Lo SC, Stewart JA, Stewart WC. Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients. Clin Ophthalmol. 2000;4:1355–9. - PMC - PubMed

MeSH terms